KIMBERLY JOHNSON: Open Payments
NPI 1386391555 · HEMET, CA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$417 in 26 payments from 9 companies in 2025. Trend: 2023 $692 · 2024 $502 · 2025 $417
Food & beverage: $417
| Company | Payments | Amount |
|---|---|---|
| Ardelyx, Inc. | 12 | $150 |
| Fresenius USA Marketing, Inc. | 4 | $79 |
| AstraZeneca Pharmaceuticals LP | 3 | $50 |
| AKEBIA THERAPEUTICS INC | 2 | $47 |
| BIOTRONIK INC. | 1 | $20 |
| Travere Therapeutics, Inc. | 1 | $20 |
| Bayer Healthcare Pharmaceuticals Inc. | 1 | $18 |
| Vifor Pharma, Inc. | 1 | $18 |
| Medtronic, Inc. | 1 | $14 |
Products named: IBSRELA, VELPHORO, Vafseo, LOKELMA, BIOMONITOR, Kerendia, Veltassa, ELLIPSYS VASCULAR ACCESS SYSTEM.
Industry payments across CA — which companies pay providers there.
